Population Characteristics and Prognostic Factors in Metastatic Non–Small-Cell Lung Cancer: A Fox Chase Cancer Center Retrospective
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference17 articles.
1. Comparison of four chemotherapy regimens for advanced non–small-cell lung cancer;Schiller;N Engl J Med,2002
2. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer [published correction appears in N Engl J Med 2007; 356:318];Sandler;N Engl J Med,2006
3. Survival determinants in extensive-stage non–small-cell lung cancer: the Southwest Oncology Group experience;Albain;J Clin Oncol,1991
4. Changes in the natural history of nonsmall cell lung cancer (NSCLC)—comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990;Wakelee;Cancer,2006
5. The noninvasive staging of non-small cell lung cancer: the guidelines;Silvestri;Chest,2003
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study;BMC Cancer;2021-11-19
2. Survival analysis and factors affecting survival in patients who presented to the medical oncology unit with non-small cell lung cancer;TURKISH JOURNAL OF MEDICAL SCIENCES;2020-12-17
3. Imaging features and prognostic value of 18F-FDG PET/CT detection of soft-tissue metastasis from lung cancer: a retrospective study;BMC Cancer;2020-06-26
4. ALK rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma;Diagnostic Pathology;2019-08-28
5. Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer;Anticancer Research;2019-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3